BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26717037)

  • 1. A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells.
    Marani M; Paone A; Fiascarelli A; Macone A; Gargano M; Rinaldo S; Giardina G; Pontecorvi V; Koes D; McDermott L; Yang T; Paiardini A; Contestabile R; Cutruzzolà F
    Oncotarget; 2016 Jan; 7(4):4570-83. PubMed ID: 26717037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes.
    Tramonti A; Paiardini A; Paone A; Bouzidi A; Giardina G; Guiducci G; Magnifico MC; Rinaldo S; McDermott L; Menendez JA; Contestabile R; Cutruzzolà F
    Arch Biochem Biophys; 2018 Sep; 653():71-79. PubMed ID: 29991441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation.
    Paone A; Marani M; Fiascarelli A; Rinaldo S; Giardina G; Contestabile R; Paiardini A; Cutruzzolà F
    Cell Death Dis; 2014 Nov; 5(11):e1525. PubMed ID: 25412303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming.
    Paiardini A; Tramonti A; Schirch D; Guiducci G; di Salvo ML; Fiascarelli A; Giorgi A; Maras B; Cutruzzolà F; Contestabile R
    Biochim Biophys Acta; 2016 Nov; 1864(11):1506-17. PubMed ID: 27530298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catalytic activity of serine hydroxymethyltransferase is essential for de novo nuclear dTMP synthesis in lung cancer cells.
    Giardina G; Paone A; Tramonti A; Lucchi R; Marani M; Magnifico MC; Bouzidi A; Pontecorvi V; Guiducci G; Zamparelli C; Rinaldo S; Paiardini A; Contestabile R; Cutruzzolà F
    FEBS J; 2018 Sep; 285(17):3238-3253. PubMed ID: 30035852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases.
    Chang WN; Tsai JN; Chen BH; Huang HS; Fu TF
    Drug Metab Dispos; 2007 Nov; 35(11):2127-37. PubMed ID: 17664250
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties.
    Tramonti A; Nardella C; di Salvo ML; Barile A; Cutruzzolà F; Contestabile R
    Biochemistry; 2018 Dec; 57(51):6984-6996. PubMed ID: 30500180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The moonlighting RNA-binding activity of cytosolic serine hydroxymethyltransferase contributes to control compartmentalization of serine metabolism.
    Guiducci G; Paone A; Tramonti A; Giardina G; Rinaldo S; Bouzidi A; Magnifico MC; Marani M; Menendez JA; Fatica A; Macone A; Armaos A; Tartaglia GG; Contestabile R; Paiardini A; Cutruzzolà F
    Nucleic Acids Res; 2019 May; 47(8):4240-4254. PubMed ID: 30809670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma.
    Ducker GS; Ghergurovich JM; Mainolfi N; Suri V; Jeong SK; Hsin-Jung Li S; Friedman A; Manfredi MG; Gitai Z; Kim H; Rabinowitz JD
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11404-11409. PubMed ID: 29073064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugs.
    Scaletti E; Jemth AS; Helleday T; Stenmark P
    FEBS Lett; 2019 Jul; 593(14):1863-1873. PubMed ID: 31127856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How pyridoxal 5'-phosphate differentially regulates human cytosolic and mitochondrial serine hydroxymethyltransferase oligomeric state.
    Giardina G; Brunotti P; Fiascarelli A; Cicalini A; Costa MG; Buckle AM; di Salvo ML; Giorgi A; Marani M; Paone A; Rinaldo S; Paiardini A; Contestabile R; Cutruzzolà F
    FEBS J; 2015 Apr; 282(7):1225-41. PubMed ID: 25619277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide biosynthesis arrest by silencing SHMT1 function via vitamin B6-coupled vector and effects on tumor growth inhibition.
    Pandey S; Garg P; Lee S; Choung HW; Choung YH; Choung PH; Chung JH
    Biomaterials; 2014 Nov; 35(34):9332-42. PubMed ID: 25132602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression.
    Yang Y; Zhang M; Zhao Y; Deng T; Zhou X; Qian H; Wang M; Zhang C; Huo Z; Mao Z; Shao Z; Liu M; Yang C; Lin C; Xu F; Tian G; Zhang Y
    Cancer Sci; 2023 Dec; 114(12):4583-4595. PubMed ID: 37752684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.
    Witschel MC; Rottmann M; Schwab A; Leartsakulpanich U; Chitnumsub P; Seet M; Tonazzi S; Schwertz G; Stelzer F; Mietzner T; McNamara C; Thater F; Freymond C; Jaruwat A; Pinthong C; Riangrungroj P; Oufir M; Hamburger M; Mäser P; Sanz-Alonso LM; Charman S; Wittlin S; Yuthavong Y; Chaiyen P; Diederich F
    J Med Chem; 2015 Apr; 58(7):3117-30. PubMed ID: 25785478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization.
    Hebbring SJ; Chai Y; Ji Y; Abo RP; Jenkins GD; Fridley B; Zhang J; Eckloff BW; Wieben ED; Weinshilboum RM
    J Neurochem; 2012 Mar; 120(6):881-90. PubMed ID: 22220685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and in vitro testing of antifolate inhibitors of human cytosolic serine hydroxymethyltransferase.
    Paiardini A; Fiascarelli A; Rinaldo S; Daidone F; Giardina G; Koes DR; Parroni A; Montini G; Marani M; Paone A; McDermott LA; Contestabile R; Cutruzzolà F
    ChemMedChem; 2015 Mar; 10(3):490-7. PubMed ID: 25677305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy.
    Renwick SB; Snell K; Baumann U
    Structure; 1998 Sep; 6(9):1105-16. PubMed ID: 9753690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.
    Schwertz G; Witschel MC; Rottmann M; Leartsakulpanich U; Chitnumsub P; Jaruwat A; Amornwatcharapong W; Ittarat W; Schäfer A; Aponte RA; Trapp N; Chaiyen P; Diederich F
    ChemMedChem; 2018 May; 13(9):931-943. PubMed ID: 29655285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma.
    Wu S; Zhang G; Li P; Chen S; Zhang F; Li J; Jiang C; Chen X; Wang Y; Du Y; Sun Q; Zhao G
    Tumour Biol; 2016 Apr; 37(4):5193-202. PubMed ID: 26553359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.